Cambridge Investment Research Advisors, Inc. Bristol Myers Squibb CO Transaction History

Cambridge Investment Research Advisors, Inc.

  • $32.9 Billion
  • Q2 2025

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 386,312 shares of BMY stock, worth $17.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
386,312
Previous 462,142 16.41%
Holding current value
$17.8 Million
Previous $28.2 Million 36.56%
% of portfolio
0.05%
Previous 0.1%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
SELL
$44.12 - $59.6 $3.35 Million - $4.52 Million
-75,830 Reduced 16.41%
386,312 $17.9 Million
Q1 2025

Apr 22, 2025
SELL
$53.9 - $63.11 $2.78 Million - $3.26 Million
-51,585 Reduced 10.04%
462,142 $28.2 Million
Q4 2024

Feb 14, 2025
BUY
$51.92 - $59.94 $7.12 Million - $8.22 Million
137,203 Added 36.44%
513,727 $29.1 Million
Q3 2024

Oct 28, 2024
BUY
$39.66 - $51.75 $677,630 - $884,200
17,086 Added 4.75%
376,524 $19.5 Million
Q2 2024

Jul 26, 2024
SELL
$40.25 - $52.99 $2.44 Million - $3.21 Million
-60,504 Reduced 14.41%
359,438 $14.9 Million
Q1 2024

Apr 24, 2024
SELL
$47.98 - $54.4 $595,863 - $675,593
-12,419 Reduced 2.87%
419,942 $22.8 Million
Q4 2023

Feb 09, 2024
SELL
$48.48 - $57.85 $1.79 Million - $2.14 Million
-37,023 Reduced 7.89%
432,361 $22.2 Million
Q3 2023

Oct 24, 2023
SELL
$57.89 - $64.73 $3.58 Million - $4 Million
-61,803 Reduced 11.63%
469,384 $27.2 Million
Q2 2023

Jul 13, 2023
SELL
$63.71 - $70.74 $3.35 Million - $3.72 Million
-52,634 Reduced 9.02%
531,187 $34 Million
Q1 2023

May 11, 2023
BUY
$65.71 - $74.53 $6.56 Million - $7.44 Million
99,775 Added 20.61%
583,821 $40.5 Million
Q4 2022

Feb 08, 2023
BUY
$68.48 - $81.09 $1.07 Million - $1.27 Million
15,637 Added 3.34%
484,046 $34.8 Million
Q3 2022

Oct 17, 2022
SELL
$0.13 - $76.84 $783 - $463,037
-6,026 Reduced 1.27%
468,409 $33.3 Million
Q2 2022

Jul 13, 2022
BUY
$72.62 - $79.98 $839,850 - $924,968
11,565 Added 2.5%
474,435 $36.5 Million
Q1 2022

May 12, 2022
SELL
$61.48 - $73.72 $548,032 - $657,140
-8,914 Reduced 1.89%
462,870 $33.8 Million
Q4 2021

Feb 03, 2022
BUY
$53.63 - $62.52 $1.05 Million - $1.23 Million
19,601 Added 4.33%
471,784 $29.4 Million
Q3 2021

Nov 02, 2021
SELL
$59.17 - $69.31 $41.8 Million - $49 Million
-707,141 Reduced 61.0%
452,183 $26.8 Million
Q2 2021

Aug 10, 2021
SELL
$61.91 - $67.42 $3.71 Million - $4.04 Million
-59,973 Reduced 4.92%
1,159,324 $77.5 Million
Q1 2021

May 07, 2021
SELL
$59.34 - $66.74 $7.86 Million - $8.84 Million
-132,487 Reduced 9.8%
1,219,297 $77 Million
Q4 2020

Feb 04, 2021
SELL
$57.74 - $65.43 $1.87 Million - $2.12 Million
-32,354 Reduced 2.34%
1,351,784 $83.9 Million
Q3 2020

Oct 29, 2020
BUY
$57.43 - $63.64 $54.1 Million - $59.9 Million
941,541 Added 212.73%
1,384,138 $83.4 Million
Q2 2020

Jul 27, 2020
BUY
$54.82 - $64.09 $1.42 Million - $1.66 Million
25,973 Added 6.23%
442,597 $26 Million
Q1 2020

May 08, 2020
BUY
$46.4 - $67.43 $550,953 - $800,663
11,874 Added 2.93%
416,624 $23.2 Million
Q4 2019

Feb 04, 2020
BUY
$49.21 - $64.19 $7.73 Million - $10.1 Million
157,161 Added 63.48%
404,750 $26 Million
Q3 2019

Nov 06, 2019
BUY
$42.77 - $50.71 $399,172 - $473,276
9,333 Added 3.92%
247,589 $12.6 Million
Q3 2019

Oct 28, 2019
SELL
$42.77 - $50.71 $13,344 - $15,821
-312 Reduced 0.13%
238,256 $12.1 Million
Q2 2019

Aug 15, 2019
BUY
$44.62 - $49.34 $841,756 - $930,799
18,865 Added 8.59%
238,568 $0
Q1 2019

May 08, 2019
BUY
$45.12 - $53.8 $556,735 - $663,838
12,339 Added 5.95%
219,703 $0
Q4 2018

Feb 05, 2019
SELL
$48.76 - $63.23 $1.14 Million - $1.48 Million
-23,466 Reduced 10.17%
207,364 $10.8 Million
Q3 2018

Nov 02, 2018
BUY
$55.19 - $62.25 $764,381 - $862,162
13,850 Added 6.38%
230,830 $0
Q2 2018

Aug 10, 2018
SELL
$50.53 - $62.98 $120,615 - $150,333
-2,387 Reduced 1.09%
216,980 $0
Q1 2018

May 09, 2018
BUY
$59.92 - $68.98 $589,552 - $678,694
9,839 Added 4.7%
219,367 $0
Q4 2017

Feb 22, 2018
BUY
$59.94 - $65.35 $1.28 Million - $1.4 Million
21,391 Added 11.37%
209,528 $0
Q3 2017

Nov 07, 2017
BUY
$55.23 - $63.74 $703,464 - $811,856
12,737 Added 7.26%
188,137 $12 Million
Q2 2017

Aug 08, 2017
BUY
N/A
175,400
175,400 $9.77 Million

Others Institutions Holding BMY

# of Institutions
2,668
Shares Held
1.64B
Call Options Held
22.5M
Put Options Held
25.3M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $98B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email